Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions

Rhea-AI Summary

Senseonics Holdings, a medical technology company specializing in long-term, implantable continuous glucose monitoring systems for diabetes patients, has announced a business update and analyst event. This will take place during the American Diabetes Association’s 84th Scientific Sessions in Orlando, FL. The event is scheduled for Sunday, June 23, 2024, with breakfast and refreshments starting at 9:15 am ET, followed by a management presentation at 10:00 am ET. Attendees can access the presentation via live and recorded webcast on the company's website. In-person attendance requires advanced registration by June 21, 2024, through emailing Hannah Jeffrey at hannah@gilmartinir.com.

Positive

• Senseonics is engaging with analysts and investors at a high-profile event, indicating transparency and openness.
• The event is part of the American Diabetes Association’s 84th Scientific Sessions, aligning the company with a reputable organization.
• Providing both live and recorded webcasts broadens accessibility and investor engagement.

Negative

• No specific financial or clinical data updates were provided in the announcement, leaving investors anticipating concrete results.
• The need for advanced registration could limit spontaneous participation, potentially reducing the event's reach.

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to host a business update and analyst event during the American Diabetes Association’s 84^th Scientific Sessions in Orlando, FL.

Breakfast and refreshments will be provided beginning at 9:15 am ET on Sunday, June 23, 2024, in advance of a business update presentation from management scheduled to begin, at 10:00 am ET. Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.

In-person attendance for the event requires advanced registration. Please email Hannah Jeffrey at hannah@gilmartinir.com by June 21, 2024, to register.

About Senseonics

Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics’ CGM system Eversense® E3 includes a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user’s smartphone.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240613143680/en/

Senseonics Investor Contact

Philip Taylor

Gilmartin Group

415-937-5406

Investors@senseonics.com

Source: Senseonics Holdings, Inc.

FAQ

What is the date and time for Senseonics' business update and analyst event?

Senseonics' business update and analyst event will take place on Sunday, June 23, 2024, with the presentation starting at 10:00 am ET.

How can one attend Senseonics' analyst event in person?

To attend in person, one must register by emailing Hannah Jeffrey at hannah@gilmartinir.com by June 21, 2024.

Where can I access the live and recorded webcast of Senseonics' business update?

The webcast will be available on the 'Investor Relations' section of the Senseonics website at www.senseonics.com.

What is the stock symbol for Senseonics Holdings?

The stock symbol for Senseonics Holdings is SENS.

What type of event will Senseonics host during the ADA’s 84th Scientific Sessions?

Senseonics will host a business update and analyst event.